Keryx Biopharmaceuticals Inc. (KERX) is in the Pharma Industry

• Sort by

• Keryx Biopharmaceuticals, Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator instructions We’ll first hear from Jonathan Aschoff of Brean Murray. Jonathan Aschoff – Brean Murray Good morning, Mike. Michael Weiss Hey, good morning, Jonathan. Jonathan Aschoff – Brean Murray I was wondering how sort of the fishing is going, the fishing for maybe something...

  Earnings calls 2008-08-11

  Tags: Keryx Biopharmaceuticals Inc.

• Keryx Biopharmaceuticals, Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator instructions okay, and I am showing that our first question comes from Jonathan Aschoff. Please go ahead. Jonathan Aschoff – Brean Murray, Carret & Co. Hi, Mike, how are you doing? Michael Weiss Hey, Jonathan. How are you today? Jonathan Aschoff – Brean...

  Earnings calls 2008-05-30

  Tags: Keryx Biopharmaceuticals Inc.

Additional Resources

• Keryx Biopharmaceuticals to Present at the Bank of America 2008 Health Care Conference

  Presentation Scheduled for Thursday, May 15th at 11:10am PT NEW YORK, May 13 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, is scheduled to present at the Bank of America 2008 Health Care Conference in Las...

  Articles 2008-05-13

• Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results

  Keryx to Host Investor Conference Call on Monday, May 12, 2008 at 8:30am EDT NEW YORK, May 9 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. , a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including...

  Articles 2008-05-09

• Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT

  NEW YORK, May 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. will hold a conference call on Monday, May 12, 2008 at 8:30 a.m. EDT to discuss the first quarter 2008 financial results. Michael S. Weiss, Chairman and Chief Executive Officer of the Company, will host the call. Keryx will...

  Articles 2008-05-08

• RAK, IDRA, KERX, POOL, JYHW, EMPIQ Have Also Been Removed From Naked Short List Today.

  M2 PRESSWIRE-28 March 2008-BUYINS.NET: RAK, IDRA, KERX, POOL, JYHW, EMPIQ Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:28032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...

  Articles 2008-03-28

• JMBA, KERX, STEN, TELK, JYHW, TMLN Have Also Been Added To Naked Short List Today.

  M2 PRESSWIRE-17 March 2008-BUYINS.NET: JMBA, KERX, STEN, TELK, JYHW, TMLN Have Also Been Added To Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:17032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and...

  Articles 2008-03-17

• Keryx Biopharmaceuticals, Inc. Presents at Cowen and Company Health Care Conference on March 17, 2008.

  M2 PRESSWIRE-14 March 2008-investorIM: Keryx Biopharmaceuticals, Inc. Presents at Cowen and Company Health Care Conference on March 17, 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:14032008 InvestorIM has been created as a tool for the average investor. The idea is simple, a...

  Articles 2008-03-14

• Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference

  Presentation Scheduled for Monday, March 17th at 11:30am ET NEW YORK, March 13 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced that I. Craig Henderson, MD, the Company's President, and Eric Grossman, MD, the Company's Vice President, Medical Affairs, are scheduled to present at the Cowen and...

  Articles 2008-03-13

• Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint

  Company to host conference call Today, Monday, March 10, 2008 at 8:30am NEW YORK, March 10 /PRNewswire-FirstCall/ -- On Friday, March 7, 2008, Keryx Biopharmaceuticals, Inc. , announced top-line results from its SUN-MICRO Phase 3 clinical trial of Sulonex sulodexide for the treatment of diabetic nephropathy. ...

  Articles 2008-03-10

• Has added Keryx Biopharmaceuticals Inc. to their watch list.

  M2 PRESSWIRE-10 March 2008-The Maybach Review: Has added Keryx Biopharmaceuticals Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:10032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers,...

  Articles 2008-03-10

• Market Review for Keryx Biopharmaceuticals, Inc.

  M2 PRESSWIRE-10 March 2008-The SI Report: Market Review for Keryx Biopharmaceuticals, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:10032008 Streetinvesting.com has now resumed our progressive review of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), after it traded down 85% Monday, early in the morning...

  Articles 2008-03-10

• BellwetherReport.com Free Analyst Review for KERX, LVLT, SPPI and ACLS

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking unbiased research on the companies mentioned inthis release are highly encouraged to sign up to www.bellwetherreport.com for a free subscription. Today we have set up interviews with a number ofthe top analysts in North...

  Articles 2008-03-10

• Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint

  Company to host a conference call Monday, March 10, 2008 at 8:30am NEW YORK, March 7 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced top-line results from its SUN-MICRO Phase 3 clinical trial of Sulonex sulodexide for the treatment of diabetic nephropathy. The Company announced that...

  Articles 2008-03-08

• Wall Street News Alert: Breaking News Alert - CPYE! February 29, 2008

  Wall Street News Alert's "stocks to watch" thismorning are: Conspiracy Entertainment Holdings Incorporated (OTCBB: CPYE),Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), Flowserve Corp. (NYSE: FLS)and Google Inc. (NASDAQ: GOOG). Having previously announced that it continues to successfully capture salesfor the gaming title Winter Sports for the Nintendo WiiTM platform,Conspiracy Entertainment Holdings Inc....

  Articles 2008-02-29

• Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results

  Keryx to Host Investor Conference Call on Monday, February 25, 2008 at 8:30am EST NEW YORK, Feb. 22 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. , a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including...

  Articles 2008-02-22

• Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST

  NEW YORK, Feb. 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. will hold a conference call on Monday, February 25, 2008 at 8:30 a.m. EST to discuss the fourth quarter and year-end 2007 financial results and business outlook for 2008. Michael S. Weiss, Chairman and Chief Executive Officer of...

  Articles 2008-02-21

• Healthcare News: Arthritis Sufferers Take Note.

  M2 PRESSWIRE-6 February 2008-Financialbusinessnews.us: Healthcare News: Arthritis Sufferers Take NoteC1994-2008 M2 COMMUNICATIONS LTD RDATE:06022008 Boston, MA -- HealthSonix, Inc. (OTC: HSXI); IPC The Hospitalist Company, Inc. (NASDAQ: IPCM); NeurogesX, Inc. (NASDAQ: NGSX); Nile Therapeutics, Inc. (OTC Bulletin Board: NILT);...

  Articles 2008-02-06

• Has added Keryx Biopharmaceuticals Inc. to their watch list.

  M2 PRESSWIRE-5 February 2008-The Maybach Journal: Has added Keryx Biopharmaceuticals Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:05022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers,...

  Articles 2008-02-05

• Current Market Review for Keryx Biopharmaceuticals, Inc.

  M2 PRESSWIRE-5 February 2008-Market Review: Current Market Review for Keryx Biopharmaceuticals, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:06022008 Streetinvesting.com has now resumed our progressive review of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) after it traded down 2% Tuesday, early in the afternoon...

  Articles 2008-02-05